Literature DB >> 3481357

HIV antigen, HIV antibody and serum interferon in a patient with encephalopathy.

J Abb1, R Zachoval, V Zachoval, F Deinhardt.   

Abstract

Acute encephalopathy was associated with the presence of human immunodeficiency virus type I (HIV I) antigen and seroconversion to anti-HIV I in a 27-year-old homosexual man. Examination of consecutive sera from the patient revealed circulating interferon (IFN) alpha which became detectable with the appearance of HIV I antigen but before development of anti-HIV I. Serum IFN was present for only a limited time and was not demonstrable after neurological symptoms resolved. It may be speculated that circulating antiviral activity contributed to the clinical manifestations of acute HIV I infection.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3481357     DOI： 10.1007/BF01647221

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  12 in total

1.  Rapid detection of immunoreactive interferon-alpha in AIDS.

Authors:  S R Abbott; E Buimovici-Klein; L Z Cooper; M Lange; M Briggs; I V Weller
Journal:  Lancet       Date:  1984-03-10       Impact factor: 79.321

2.  Recombinant leukocyte interferon treatment of chronic hepatitis B.

Authors:  G Dusheiko; A Dibisceglie; S Bowyer; E Sachs; M Ritchie; B Schoub; M Kew
Journal:  Hepatology       Date:  1985 Jul-Aug       Impact factor: 17.425

3.  Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy.

Authors:  E DeStefano; R M Friedman; A E Friedman-Kien; J J Goedert; D Henriksen; O T Preble; J A Sonnabend; J Vilcek
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

4.  Acute encephalopathy coincident with seroconversion for anti-HTLV-III.

Authors:  C A Carne; R S Tedder; A Smith; S Sutherland; S G Elkington; H M Daly; F E Preston; J Craske
Journal:  Lancet       Date:  1985-11-30       Impact factor: 79.321

5.  Long-term follow-up of serum-interferon and its acid-stability in a group of homosexual men.

Authors:  E Buimovici-Klein; M Lange; R J Klein; M H Grieco; L Z Cooper
Journal:  AIDS Res       Date:  1986

6.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

7.  Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus.

Authors:  L Montagnier; F Clavel; B Krust; S Chamaret; F Rey; F Barré-Sinoussi; J C Chermann
Journal:  Virology       Date:  1985-07-15       Impact factor: 3.616

8.  Serum interferon and clinical manifestations of infection with human T-lymphotropic virus type III.

Authors:  J Abb
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

9.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Interferon production in male homosexuals with the acquired immune deficiency syndrome (AIDS) or generalized lymphadenopathy.

Authors:  J Abb; M Kochen; F Deinhardt
Journal:  Infection       Date:  1984 Jul-Aug       Impact factor: 3.553
View more
  8 in total

1.  Acute meningoencephalitis and meningitis due to primary HIV infection.

Authors:  P J Newton; W Newsholme; N S Brink; H Manji; I G Williams; R F Miller
Journal:  BMJ       Date:  2002-11-23

Review 2.  Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development.

Authors:  Sheila M Keating; Evan S Jacobs; Philip J Norris
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

3.  Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells.

Authors:  Jean-Philippe Herbeuval; Andrew W Hardy; Adriano Boasso; Stephanie A Anderson; Matthew J Dolan; Michel Dy; Gene M Shearer
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-20       Impact factor: 11.205

4.  Suppressive effects of interferons on the production and release of human T-lymphotropic virus type-I (HTLV-I).

Authors:  T Oka; Y Ohtsuki; H Sonobe; M Furihata; I Miyoshi
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

5.  Selective decrease in human immunodeficiency virus type 1 (HIV-1)-induced alpha interferon production by peripheral blood mononuclear cells during HIV-1 infection.

Authors:  J Ferbas; J Navratil; A Logar; C Rinaldo
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

6.  Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120.

Authors:  B D Hansen; P L Nara; R K Maheshwari; G S Sidhu; J G Bernbaum; D Hoekzema; M S Meltzer; H E Gendelman
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

7.  Clinical picture of primary HIV infection presenting as a glandular-fever-like illness.

Authors:  H Gaines; M von Sydow; P O Pehrson; P Lundbegh
Journal:  BMJ       Date:  1988-11-26

Review 8.  Blocking type I interferon production: a new therapeutic option to reduce the HIV-1-induced immune activation.

Authors:  Moritz Ries; Kathrin Pritschet; Barbara Schmidt
Journal:  Clin Dev Immunol       Date:  2011-11-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.